Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc.

Overview
Date Founded

2011

Headquarters

15010 Broschart Road,Suite 250,Rockville, MD 20850

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Biotechnology
Holding Companies
Pharmaceuticals

Company Description

Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl and Thomas J. August in 2005 and is headquartered in Hershey, PA.

Contact Data
Trying to get in touch with decision makers at Immunomic Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Chief Scientific Officer

Head-Business Development

Senior Director

Lab Director

Director-Business Development

Marketing Manager

Scientist

Board of Directors

Executive Vice President at Life Sciences Greenhouse of Central Pennsylvania

Chief Financial Officer at Immunomic Therapeutics, Inc.

Former Chief Executive Officer at Lpath Inc.

Chief Executive Officer at McDonald & Associates, Inc.

Paths to Immunomic Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Immunomic Therapeutics, Inc.
Recent Transactions
Details Hidden

Immunomic Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Immunomic Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Immunomic Therapeutics, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onImmunomic Therapeutics, Inc. raised money in a private placement transaction

Clients

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company is headquartered in Tokyo, Japan.

Investors
Details Hidden

Brainchild Holdings invests in companies located in the US. They focus on business to business, consumer, e-commerce & health sector. The firm provides financing for seed, early & growth stage transactions.

Details Hidden

The Life Sciences Greenhouse of Central Pennsylvania makes pre-seed and seed stage investments in life sciences companies. Areas of particular interest to include mid- to-late stage drug design, drug delivery systems, biomedical devices, biopharmaceutical manufacturing innovation, drug assay/detection/screening systems and bionanotechnology. Investments range up to $750,000 in milestone-driven convertible debt or equity financing. They focus on investments in Central Pennsylvania.

Details Hidden

Bespoke Capital makes both equity and debt investments in innovative companies with high large growth potential.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Immunomic Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Immunomic Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Immunomic Therapeutics, Inc..